申请人:Leo Oberdan
公开号:US20090325923A1
公开(公告)日:2009-12-31
The present invention relates to the use of an inhibitor of the formation of nicotinamide adenyl dinucleotide for the preparation of a medicament used in the treatment of inflammatory diseases such as rheumatoid arthritis and endotoxemia.